Leprosy

Lockwood, 2004, Leprosy, vol. 2, 29.1 Global leprosy situation, 2005, 2005, Wkly Epidemiol Rec, 80, 289 Britton, 2004, Leprosy, Lancet, 363, 1209, 10.1016/S0140-6736(04)15952-7 Ridley, 1966, Classification of leprosy according to immunity, Int J Lepr, 34, 255 van Brakel, 2005, The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India, Lepr Rev, 76, 14, 10.47276/lr.76.1.14 www.who.int/lep/disease/Eliminate_Leprosy_V8.pdf Pfaltzgraff, 1994, Clinical leprosy, 237 Lockwood, 2001, The diagnosis of leprosy is delayed in the United Kingdom, Q J Med, 94, 207, 10.1093/qjmed/94.4.207 Brand, 1959, Temperature variation and leprosy deformity, Int J Lepr, 27, 1 Abraham, 1997, Diffuse alopecia of the scalp in borderline-lepromatous leprosy in an Indian patient, Lepr Rev, 68, 336 Gummer, 1983, The distribution of Mycobacterium leprae in the hair follicle of the eyebrow, Int J Lepr Other Mycobact Dis, 51, 205 Pakti, 1991, Significance of nail changes in leprosy: a clinical review of 357 cases, Semin Dermatol, 10, 77 Croft, 1999, Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study), Lepr Rev, 70, 140 Facer, 1998, Correlation of quantitative tests of nerve and target organ dysfunction with skin immunohistology in leprosy, Brain, 121, 2239, 10.1093/brain/121.12.2239 van Brakel, 1994, Silent neuropathy in leprosy: an epidemiological description, Lepr Rev, 65, 350 ffytche, 1998, The prevalence of disabling ocular complications of leprosy: a global study, Indian J Lepr, 70, 49 van Brakel, 1994, Reactions in leprosy: an epidemiological study of 386 patients in West Nepal, Lepr Rev, 65, 190 Manandhar, 1999, Risk factors for erythema nodosum leprosum, Int J Lepr Other Mycobact Dis, 67, 270 Sarno, 1991, Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states, Clin Exp Immunol, 84, 103 Rijal, 2004, Bullous erythema nodosum leprosum: a case report from Nepal, Lepr Rev, 75, 177, 10.47276/lr.75.2.177 Moschella, 1968, Primary diffuse lepromatous leprosy with erythema necrotisans (Lucio phenomenon), Arch Dermatol, 97, 593, 10.1001/archderm.97.5.593 Sehgal, 1987, Contemplative immune mechanism of Lucio phenomenon and its global status, J Dermatol, 14, 580, 10.1111/j.1346-8138.1987.tb03630.x Lockwood, 1999, Pregnancy and leprosy: a comprehensive literature review, Int J Lepr Other Mycobact Dis, 67, 6 Ustianowski, 2006, Interactions between HIV infection and leprosy: a paradox, Lancet Infect Dis, 6, 350, 10.1016/S1473-3099(06)70493-5 Faye, 2005, High prevalence of non-leprotic hypochromic patches among children in a rural area of Mali, West Africa, Lepr Rev, 76, 144, 10.47276/lr.76.2.144 Naik, 1985, Thickening of peripheral nerves in neurofibromatosis, Indian J Lepr, 57, 876 World Health Organisation, 1982, Chemotherapy of leprosy for control programmes, 675 Lockwood, 2004, Treatment of leprosy, BMJ, 328, 1447, 10.1136/bmj.328.7454.1447 www.clinicalevidence.com Jopling, 1976, Complications of treatment with clofazimine (Lamprene: B663), Lepr Rev, 47, 1 Atkinson, 1967, Evaluation of B.663 in human leprosy, Int J Lepr Other Mycobact Dis, 35, 119 Degowin, 1966, The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency, Bull World Health Organ, 35, 165 Tomecki, 2001, An intensive self care training programme reduces admissions for the treatment of plantar ulcers, Lepr Rev, 72, 276 Simons, 1980, Minocycline and generalized cutaneous pigmentation, J Am Acad Dermatol, 33, 244, 10.1016/S0190-9622(80)80186-1 Croft, 2003, A clinical prediction rule for nerve function impairment in leprosy patients-revisited after 5 years of follow-up, Lepr Rev, 74, 35, 10.47276/lr.74.1.35 van Brakel, 1996, Nerve function impairment in leprosy: a clinical and epidemiological study—Part 2 Results of steroid treatment, Lepr Rev, 67, 104 Smith, 2004, Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1), BMJ, 328, 1459, 10.1136/bmj.38107.645926.AE 1977, WHO Expert Committee on Leprosy—Fifth Report, 607 Moreira, 1998, Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL, Int J Lepr Other Mycobact Dis, 66, 61 Cross, 2001, An intensive self care training programme reduces admissions for the treatment of plantar ulcers, Lepr Rev, 72, 276 Nicholls, 2000, Guidelines for social and economic rehabilitation, Lepr Rev, 71, 422